Pelthos Therapeutics Inc. (PTHS) — 10-Q Filings

10-Q Filings (6)

• Pelthos Swings to $21.7M Loss Post-Merger, ZELSUVMI Drives Revenue — Nov 13, 2025 Risk: high
  Pelthos Therapeutics Inc. (PTHS) reported a significant operational shift and financial performance for the nine months ended September 30, 2025, following its
• Pelthos' Losses Mount Amid Cash Crunch, Going Concern Doubts — Aug 13, 2025 Risk: high
  Pelthos Therapeutics Inc. (PTHS) reported a significant increase in net loss for the six months ended June 30, 2025, reaching $5.4 million, up from $4.3 million
• Channel Therapeutics Corp. Files Q1 2025 10-Q — May 13, 2025 Risk: low
  Channel Therapeutics Corp. filed its 10-Q for the period ending March 31, 2025. The company, formerly Chromocell Therapeutics Corp, is incorporated in Nevada an
• Chromocell Therapeutics Files Q3 2024 10-Q — Nov 13, 2024 Risk: medium
  Chromocell Therapeutics Corp filed its 10-Q for the period ending September 30, 2024. The company, located at 685 US Highway One, North Brunswick, NJ, is involv
• Chromocell Therapeutics Files Q2 2024 10-Q — Aug 13, 2024 Risk: medium
  Chromocell Therapeutics Corp filed its 10-Q for the period ending June 30, 2024. The company reported financial results and operational updates. Specific financ
• Chromocell Therapeutics Corp Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: low
  Chromocell Therapeutics Corp (PTHS) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Chromocell Therapeutics Corp filed a 10-Q report for the perio

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX